SH2D2A
Basic information
Region (hg38): 1:156806240-156816848
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SH2D2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 19 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 0 | 19 | 7 | 6 |
Variants in SH2D2A
This is a list of pathogenic ClinVar variants found in the SH2D2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-156807267-C-G | not specified | Likely benign (Mar 02, 2023) | ||
1-156807305-A-T | not specified | Uncertain significance (Mar 15, 2024) | ||
1-156809222-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
1-156809237-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
1-156809289-C-G | not specified | Uncertain significance (Nov 29, 2023) | ||
1-156809289-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
1-156809396-G-T | not specified | Uncertain significance (Nov 08, 2022) | ||
1-156809402-C-T | not specified | Uncertain significance (Jun 22, 2024) | ||
1-156809429-A-T | not specified | Uncertain significance (Apr 06, 2023) | ||
1-156809442-G-C | not specified | Uncertain significance (Jul 14, 2023) | ||
1-156809448-G-A | not specified | Uncertain significance (Nov 03, 2022) | ||
1-156809663-C-G | not specified | Uncertain significance (Mar 29, 2022) | ||
1-156809672-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
1-156813865-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
1-156813891-A-G | not specified | Uncertain significance (Jul 07, 2022) | ||
1-156813931-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
1-156813933-G-T | not specified | Likely benign (Jan 16, 2024) | ||
1-156813961-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
1-156814261-C-G | not specified | Uncertain significance (Oct 28, 2023) | ||
1-156814269-T-C | not specified | Uncertain significance (Dec 07, 2021) | ||
1-156815073-G-T | not specified | Uncertain significance (Oct 12, 2021) | ||
1-156815121-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
1-156815131-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
1-156815172-C-T | not specified | Likely benign (Jan 16, 2024) | ||
1-156815564-T-C | Benign (Jun 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SH2D2A | protein_coding | protein_coding | ENST00000392306 | 8 | 10620 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.27e-7 | 0.755 | 125695 | 0 | 50 | 125745 | 0.000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.483 | 200 | 220 | 0.908 | 0.0000117 | 2532 |
Missense in Polyphen | 50 | 69.742 | 0.71693 | 904 | ||
Synonymous | 1.04 | 77 | 89.6 | 0.860 | 0.00000480 | 825 |
Loss of Function | 1.27 | 12 | 17.8 | 0.675 | 8.61e-7 | 194 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000737 | 0.000713 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000470 | 0.0000462 |
European (Non-Finnish) | 0.000117 | 0.000114 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000468 | 0.000457 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Could be a T-cell-specific adapter protein involved in the control of T-cell activation. May play a role in the CD4-p56- LCK-dependent signal transduction pathway. Could also play an important role in normal and pathological angiogenesis. Could be an adapter protein that facilitates and regulates interaction of KDR with effector proteins important to endothelial cell survival and proliferation.;
- Pathway
- VEGF signaling pathway - Homo sapiens (human);VEGFA-VEGFR2 Signaling Pathway;EGF-EGFR Signaling Pathway;Signal Transduction;VEGFA-VEGFR2 Pathway;TCR;ErbB1 downstream signaling;Signaling by VEGF;Signaling by Receptor Tyrosine Kinases;VEGF;Signaling events mediated by VEGFR1 and VEGFR2
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.562
- rvis_EVS
- 0.53
- rvis_percentile_EVS
- 80.82
Haploinsufficiency Scores
- pHI
- 0.219
- hipred
- N
- hipred_score
- 0.461
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.350
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sh2d2a
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- angiogenesis;signal transduction;cell population proliferation;positive regulation of signal transduction;cell differentiation;vascular endothelial growth factor receptor signaling pathway
- Cellular component
- cytoplasm;cytosol
- Molecular function
- SH3/SH2 adaptor activity;protein binding;SH3 domain binding